Johnson & Johnson (JNJ) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $269.99 (-0.09%), Market cap $557.82B, P/E ratio 26.88, 52-week low–high $149.79 ~ $248.56.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through whol
Financial statements, price targets, institutional (13F) holdings and related news for Johnson & Johnson are updated in real time on BlackAll Trade.
11 recent posts · 5 bullish · 0 bearish · 6 neutral.
Johnson & Johnson trades at $269.99 (-0.09%). Real-time quotes and charts are available on BlackAll Trade.
Johnson & Johnson has a market cap of about $557.82B. Its P/E ratio is 26.88.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments,